Bortezomib for the treatment of multiple myeloma

• Published in: Cochrane database of systematic reviews Vol. 4; p. CD010816
• Main Authors: Scott, Kathleen, Hayden, Patrick J, Will, Andrea, Wheatley, Keith, Coyne, Imelda
• Format: Journal Article
• Language: English
• Published: England 20.04.2016
• Subjects: Antineoplastic Agents - therapeutic use; Bortezomib - therapeutic use; Humans; Multiple Myeloma - drug therapy; Randomized Controlled Trials as Topic

Multiple myeloma is a malignancy of plasma cells accounting for approximately 1% of cancers and 12% of haematological malignancies. The first-in-class proteasome inhibitor, bortezomib, is commonly used to treat newly diagnosed as well as relapsed/refractory myeloma, either as single agent or combine...